A panel of biological tests reveals developmental effects of pharmaceutical pollutants on late stage zebrafish embryos
Authors:
- Yobhana QuirozYQYobhana Quiroz
- Audrey VonckenAVAudrey Voncken
- Nathalie JeanrayNJNathalie Jeanray
- Amandine PiotAPAmandine Piot
- Joseph A. MartialJMJoseph A. Martial
- Marc MullerMarc Muller
- 1 December 2012
- journal article
- Published by Elsevier in Reproductive Toxicology
- Vol. 34 (4) , 568-583
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific researchAquatic Toxicology, 2010
- Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake RegulationScience, 2010
- Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafishBehavioural Brain Research, 2009
- Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineagesNature Chemical Biology, 2009
- Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse modelNeuroscience, 2008
- Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryoGenome Biology, 2007
- Low doses of caffeine reduce heart rate during submaximal cycle ergometryJournal of the International Society of Sports Nutrition, 2007
- Effects of RAS on the genesis of embryonal rhabdomyosarcomaGenes & Development, 2007
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995